CVRx (CVRX) vs Picard Medical (PMI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Picard Medical (PMI) has outperformed CVRx (CVRX) over the past year, losing 94.0% versus a loss of 94.9%. Picard Medical is the larger company by market cap ($18.1 million vs $14.3 million), about 1.3 times the size. CVRx converts more of its revenue into profit, with a net margin of -94.1% versus -546.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | PMI |
|---|---|---|
| Share price | $0.501 | $6.79 |
| Market cap | $14.27M | $18.07M |
| 1-day change | -5.99% | +7.78% |
| YTD return | -92.94% | -92.24% |
| 1-year return | -94.91% | -94.02% |
| 5-year return | -96.13% | — |
| P/E ratio (TTM) | — | 3.04 |
| EPS (TTM) | $-2.00 | $2.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $56.65M | $4.94M |
| Revenue growth (YoY) | +10.45% | +12.50% |
| Net income (latest FY) | $-53.31M | $-27.00M |
| Gross margin | 85.33% | -4.13% |
| Operating margin | -90.49% | -268.36% |
| Net margin | -94.10% | -546.60% |
| 52-week high | $10.28 | $208.00 |
| 52-week low | $0.497 | $2.65 |
| Distance from 52-week high | -95.13% | -96.74% |
| Analyst consensus | none | — |
| Avg. price target upside | +814.17% | — |
| Average volume | 744.45K | 1.45M |
| Shares outstanding | 28.49M | 2.66M |
| Employees | 223 | 75 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CVRx is more profitable, keeping -94.1 cents of every revenue dollar as net income versus -546.6 cents for Picard Medical.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Health Care · Medical/Dental Instruments · 223 employees
About Picard Medical
PMI stock →Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
Health Care · Medical/Dental Instruments · 75 employees
CVRX vs PMI FAQ
Which is bigger, CVRx or Picard Medical?
Picard Medical (PMI) is larger, with a market capitalization of $18.07M compared with $14.27M for CVRx (CVRX).
Which stock has performed better over the past year, CVRX or PMI?
PMI returned -94.02% over the past 12 months, compared with -94.91% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and Picard Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.